AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1497689
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg ISMN b.i.d. morning and early afternoon
Trial: 6128331
Drug: Piracetam (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piracetam (40 g, i.v.)
Trial: 28408193
Drug: Imipramine (25-75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (25-75 mg daily for 10 weeks)
Trial: 11759980
Drug: 50 mcg
RxNorm normalized name: D3, 50 mcg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mcg oral misoprostol every 4 hours
Trial: 11759980
Drug: 50 mcg
RxNorm normalized name: D3, 50 mcg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mcg oral misoprostol every 6 hours
Trial: 9158880
Drug: Single-dose (SD)
RxNorm normalized name: Alphanine SD
DrugBank: Coagulation Factor IX Human (DB13152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose (SD) MDL 26479 ranging from 2 to 465 mg
Trial: 9158880
Drug: Multiple-dose (MD)
RxNorm normalized name: miconazole nitrate Topical Solution [Nail MD]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose (MD) MDL 26479 at doses of 30, 60, and 120 mg administered twice daily for 28 days
Trial: 9158880
Drug: Single-dose (SD)
RxNorm normalized name: Alphanine SD
DrugBank: Coagulation Factor IX Human (DB13152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose (SD) and multiple-dose (MD) MDL 26479
Trial: 7962378
Drug: Pulsatile subcutaneous
RxNorm normalized name: PULSATILLA PRATENSIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsatile subcutaneous gonadotrophin administration
Trial: 7962378
Drug: Single daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single daily bolus intramuscular gonadotrophin administration
Trial: 3656939
Drug: Low concentration
RxNorm normalized name: Dianeal Low Calcium 1.5 Intraperitoneal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low concentration dialysate (L; Na 126 mmol/liter)
Trial: 11552204
Drug: Carbidopa L-dopa
RxNorm normalized name: carbidopa / levodopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbidopa L-dopa (Sinemet)
Trial: 26443493
Drug: Stepped care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepped care trauma-focused cognitive behavioral therapy (SC-TF-CBT)
Trial: 26443493
Drug: Standard trauma-focused
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard trauma-focused cognitive behavioral therapy (TF-CBT)
Trial: 21400797
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion of analgesics and anaesthetics
Trial: 10426243
Drug: Paracervical block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracervical block using 10 mL of 2% lignocaine
Trial: 7564725
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral lysine acetylsalicylate (900 mg) and metoclopramide (10 mg)
Trial: 11200792
Drug: Oral sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sumatriptan (100 mg)
Trial: 7564725
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral lysine acetylsalicylate and metoclopramide
Trial: 30768732
Drug: Eplerenone 50
RxNorm normalized name: eplerenone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 50 mg/day (eGFR ≥ 50 mL/min/1.73 m2)
Trial: 30768732
Drug: Eplerenone 25
RxNorm normalized name: eplerenone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 25 mg/day (eGFR 30-49 mL/min/1.73 m2)
Trial: 30768732
Drug: Placebo (eGFR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (eGFR ≥ 50 mL/min/1.73 m2)
Trial: 30768732
Drug: Placebo (eGFR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (eGFR 30-49 mL/min/1.73 m2)
Trial: 30768732
Drug: Eplerenone (eGFR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone (eGFR 30-49 mL/min/1.73 m2)
Trial: 15465627
Drug: Polymorphisms of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polymorphisms of genes located on chromosome 10 involved in cholesterol metabolism (LIPA, CH25H, FLJ22476)
Trial: 11460544
Drug: Glycolic acid
RxNorm normalized name: Glycolic Acid
DrugBank: Glycolic acid (DB03085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glycolic acid cream (8% concentration)
Trial: 11460544
Drug: Glycolic acid
RxNorm normalized name: Glycolic Acid
DrugBank: Glycolic acid (DB03085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glycolic acid cream (4% concentration)
Trial: 11460544
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream (vehicle)
Trial: 9879196
Drug: Hypotensive anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypotensive anesthesia with prostaglandin E1 (PGE1) and autologous blood transfusion (400 ml)
Trial: 19793402
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg scopolamine
Trial: 26665759
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy combined with Prolit super septo (10 day course)
Trial: 12609560
Drug: Tamoxifen 20
RxNorm normalized name: tamoxifen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20 mg per day plus CR BNO 1055 (20 mg of herbal drug) for 12 months (intervention group, n=90)
Trial: 12609560
Drug: Tamoxifen 20
RxNorm normalized name: tamoxifen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20 mg per day (usual-care group, n=46)
Trial: 9466128
Drug: 9 g
RxNorm normalized name: Publix Pen Needle 29 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9 g of fish oil per day
Trial: 9466128
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g of fish oil (placebo)
Trial: 9466128
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g of fish oil per day
Trial: 9466128
Drug: 6 g
RxNorm normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g of fish oil per day
Trial: 8448746
Drug: UFT (300-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT (300-400 mg/d for 2 years)
Trial: 31109001
Drug: Sevelamer carbonate
RxNorm normalized name: Sevelamer Carbonate
DrugBank: Sevelamer (DB00658)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevelamer carbonate (4.8 g) three times a day for 12 weeks
Trial: 26486857
Drug: Customized Short
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Customized Short Messaging Service (SMS) reminders for 2 months, including personalized daily medication reminders and twice weekly health information SMS.
Trial: 21177789
Drug: NNC126‐0083 (0.01,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NNC126‐0083 (0.01, 0.02, 0.04, and 0.08 mg/kg) given subcutaneously once weekly for 3 weeks
Trial: 21177789
Drug: NNC126‐0083 (0.01,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NNC126‐0083 (0.01, 0.02, 0.04, and 0.08 mg/kg)
Trial: 19856792
Drug: Rabeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole (20 mg) - Itopride (150 mg) fixed dose combination (FDC)
Trial: 12571611
Drug: Rosiglitazone 4
RxNorm normalized name: rosiglitazone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 4 mg b.i.d.
Trial: 1710669
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment program for pain control
Trial: 6367859
Drug: Five drugs
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five drugs (CMFVP)
Trial: 6367859
Drug: Three drugs
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three drugs (CMF)
Trial: 6367859
Drug: Non-cross-reacting drug
RxNorm normalized name: Red Cross Canker Sore
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-cross-reacting drug combination
Trial: 29411270
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E softgel (300 mg/day)
Trial: 23242728
Drug: Polyhexamethylene biguanide
RxNorm normalized name: Polyhexamethylene Biguanide
DrugBank: Polihexanide (DB12277)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyhexamethylene biguanide vaginal suppositories
Trial: 23242728
Drug: Chlorhexidine digluconate
RxNorm normalized name: Chlorhexidine digluconate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine digluconate vaginal suppositories
Trial: 20728066
Drug: 1mg morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1mg morphine plus 5mg ketamine/bolus (group MK)
Trial: 20728066
Drug: 2mg/bolus morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2mg/bolus morphine (group MO)
Trial: 18093117
Drug: Medical on-treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medical on-treatment review
Trial: 14580054
Drug: Dolasetron 1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolasetron 1.8 mg kg(‐1)
Trial: 14580054
Drug: Ondansetron 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 0.15 mg kg(‐1)
Trial: 31149930
Drug: Pregabalin alone
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin alone (150 mg preoperatively and twice daily for 14 days)
Trial: 29566463
Drug: Twice-weekly supervised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly supervised physical training sessions in a fitness center
Trial: 23154549
Drug: Endostatin treatment
RxNorm normalized name: Pentostatin
DrugBank: Pentostatin (DB00552)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Endostatin treatment (paclitaxel + carboplatin + endostatin)
Trial: 17404163
Drug: Sibutramine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine (15 mg)
Trial: 19937362
Drug: Sibutramine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine plus Metformin (15 mg + 1,700 mg)
Trial: 19114406
Drug: Test meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test meal (200 g boiled white rice with 50 g natto, 60 g Japanese yams, and 40 g okras)
Trial: 19114406
Drug: Control meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control meal (200 g white rice with non-viscous boiled soybeans, potatoes, and broccoli)
Trial: 12530340
Drug: Risperidone (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (daily dosing)
Trial: 12530340
Drug: Risperidone (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (twice daily dosing)
Trial: 1860008
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 mg/24 h, increased to 100 mg/24 h after 16 months, thiazide added after 30 months)
Trial: 6225482
Drug: spectinomycin 2
RxNorm normalized name: spectinomycin 2 g intramuscular powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: spectinomycin 2 g intramuscularly (group A)
Trial: 6225482
Drug: cefamandole 1
RxNorm normalized name: cefamandole 1 g injectable powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cefamandole 1 g intramuscularly after probenecid 1 g orally (group B)
Trial: 6225482
Drug: cefaclor 3
RxNorm normalized name: cefaclor 375 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cefaclor 3 g orally with probenecid 1 g orally (group C)
Trial: 6225482
Drug: cefaclor 3
RxNorm normalized name: cefaclor 375 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cefaclor 3 g orally (group D)
Trial: 25828362
Drug: secukinumab 1
RxNorm normalized name: secukinumab 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: secukinumab 1 × 3 mg/kg on Day 1
Trial: 25828362
Drug: secukinumab 1
RxNorm normalized name: secukinumab 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: secukinumab 1 × 10 mg/kg on Day 1
Trial: 25828362
Drug: secukinumab 3
RxNorm normalized name: secukinumab 300 MG in 2 ML Auto-Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: secukinumab 3 × 10 mg/kg on Days 1, 15 and 29
Trial: 3440093
Drug: Meptazinol (0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meptazinol (0.7 mg kg‐1 and 1.4 mg kg‐1)
Trial: 3440093
Drug: Pentazocine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentazocine (0.3 mg kg‐1 and 0.6 mg kg‐1)
Trial: 25178454
Drug: Rectal temperature
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal temperature (Trec)
Trial: 17408662
Drug: SCH 503034
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 503034 200 mg plus PEG‐IFN‐alpha‐2b
Trial: 17408662
Drug: SCH 503034
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 503034 400 mg plus PEG‐IFN‐alpha‐2b
Trial: 17408662
Drug: SCH 503034
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 503034 200 mg alone
Trial: 17408662
Drug: SCH 503034
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 503034 400 mg alone
Trial: 15570081
Drug: Low-dose MPH
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose MPH (0.3 mg/kg; maximum dose, 10 mg bid)
Trial: 15570081
Drug: Moderate-dose MPH
RxNorm normalized name: MPH
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moderate-dose MPH (0.6 mg/kg; maximum dose, 20 mg bid)
Trial: 11257278
Drug: Lower plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower plasma bilirubin levels in males (12.5 micromol/l)
Trial: 8852539
Drug: Lacidipine (4-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacidipine (4-6 mg once daily)
Trial: 8852539
Drug: Hydrochlorothiazide (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (12.5 mg, titrated to 25 mg if required)
Trial: 2242077
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg temazepam
Trial: 1967533
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg temazepam
Trial: 2242077
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of temazepam
Trial: 2242077
Drug: Temazepam (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam (all doses)
Trial: 31965772
Drug: Famciclovir 250
RxNorm normalized name: famciclovir 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir 250 mg thrice daily for 1 week
Trial: 28056794
Drug: Mercury concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mercury concentration in toenails (μg per gram)
Trial: 25825853
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel preparation (MBP) with polyethylene glycol
Trial: 20624812
Drug: Short-course intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course intravenous antibiotic treatment (≤3 days)
Trial: 20624812
Drug: Long-course intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-course intravenous antibiotic treatment (≥4 days)
Trial: 18468748
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor plus ARB
Trial: 12853381
Drug: C1 inhibitor
RxNorm normalized name: C1 INHIBITOR
DrugBank: Conestat alfa (DB09228)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: C1 inhibitor therapy
Trial: 9481968
Drug: 10 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 micrograms fentanyl citrate via periodontal ligament injection
Trial: 9481968
Drug: Saline placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline placebo via periodontal ligament injection
Trial: 3357006
Drug: VAC (VCR,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAC (VCR, 1.5 mg/m2 IV days 1 and 8; CYC, 275 mg/m2 IV days 1 through 5; ACT‐D, 0.45 mg/m2 IV days 1 through 5 every 28 days for three cycles)
Trial: 3357006
Drug: VAC-M (CYC,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAC-M (CYC, 150 mg/m2 IM days 1 through 7; VCR, 2.0 mg/m2 IV day 8; ACT‐D, 1.7 mg/m2 IV day 8 every 21 days for four cycles)
Trial: 3357006
Drug: High, single-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High, single-dose ACT‐D
Trial: 26873491
Drug: Strict dose
RxNorm normalized name: Euphrasia stricta extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strict dose time instructions
Trial: 26873491
Drug: Discrepancy between
RxNorm normalized name: CYCLIZED P12 (PEPTIDE BOND BETWEEN THE CARBOXY AND AMINO-TERMINAL ENDS OF THE LINEAR PEPTIDE PSHISKYILRWRPK)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discrepancy between adherence to dose and dose schedule
Trial: 25717121
Drug: Survey administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Survey administered to all participants after the scans.
Trial: 11339516
Drug: meloxicam 7.5
RxNorm normalized name: meloxicam 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meloxicam 7.5 mg
Trial: 27307665
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (0.5 mg/kg) with ketamine (5 mg/kg) mixed in mango juice (Group MK)
Trial: 27307665
Drug: Intranasal dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal dexmedetomidine (1 μg/kg) and oral mango juice (Group DX)
Trial: 27307665
Drug: Intranasal saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal saline and oral mango juice (Group C)
Trial: 20584595
Drug: Ciclesonide 320
RxNorm normalized name: Ciclesonide
DrugBank: Ciclesonide (DB01410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciclesonide 320 μg (once daily)
Trial: 20584595
Drug: Ciclesonide 320
RxNorm normalized name: Ciclesonide
DrugBank: Ciclesonide (DB01410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciclesonide 320 μg (twice daily)
Trial: 20584595
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 200 μg (twice daily)
Trial: 20584595
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 375 μg (twice daily)
Trial: 20584595
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 500 μg (twice daily)
Trial: 17256309
Drug: Pilocarpine lozenge
RxNorm normalized name: Pilocarpine
DrugBank: Pilocarpine (DB01085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pilocarpine lozenge (5 mg)
Trial: 17256309
Drug: Pilocarpine lozenge
RxNorm normalized name: Pilocarpine
DrugBank: Pilocarpine (DB01085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pilocarpine lozenge (3 mg)
Trial: 17256309
Drug: Salagen tablet
DrugBank: Pilocarpine (DB01085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salagen tablet (control)
Trial: 17256309
Drug: Placebo lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo lozenge (control)
Trial: 8618581
Drug: Intensive chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive chemotherapy (117 patients)
Trial: 8618581
Drug: Nonrandomized intensive
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonrandomized intensive chemotherapy (189 patients)
Trial: 8452163
Drug: Norfloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin (400 mg twice daily)
Trial: 6331150
Drug: 17 g
RxNorm normalized name: lancets 17 gauge MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 g bran (B)
Trial: 6331150
Drug: 18 g
RxNorm normalized name: flotufolastat F 18 gallium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18 g bran and fruit (BF)
Trial: 26282839
Drug: Morning tobramycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning tobramycin dosing (0800 h)
Trial: 26282839
Drug: Evening tobramycin
RxNorm normalized name: Evenity
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Evening tobramycin dosing (2000 h)
Trial: 17601560
Drug: Both morning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both morning and evening dosing
Trial: 16381265
Drug: Wound instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wound instillation Group A2 (diclofenac suppository)
Trial: 16381265
Drug: Non-wound instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-wound instillation Group B2 (diclofenac suppository)
Trial: 9324693
Drug: Fibrinolytic agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinolytic agents (other patients)
Trial: 2692810
Drug: Lisuride (1.2-2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisuride (1.2-2.4 mg/day)
Trial: 2692810
Drug: Lisuride (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisuride (0.15 mg/day)
Trial: 31961490
Drug: Wait-list, treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wait-list, treatment as usual control condition